AIFM1 and cardiomyopathy: Mice with Cre-LoxP-mediated targeted deletion of AIF in striated muscle develop cardiomyopathy and skeletal muscle atrophy associated with defects in the mitochondrial respiratory chain and oxidative stress [27], [28], supporting a mitochondrial protective role for AIF.